STOCK TITAN

Embecta (NASDAQ: EMBC) investors approve directors, auditor and pay

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Embecta Corp. reported the results of its 2026 Annual Meeting of Stockholders. All seven board nominees were elected to one-year terms, each receiving more than 45 million votes in favor, with several directors exceeding 48 million "For" votes.

Stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal 2026 with 53,083,728 votes in favor. On an advisory basis, stockholders approved executive compensation, and they approved an amendment to the 2022 Employee and Director Equity-Based Compensation Plan with 41,396,703 votes for and 7,034,781 against.

Positive

  • None.

Negative

  • None.
false 0001872789 0001872789 2026-02-11 2026-02-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 11, 2026

 

 

EMBECTA CORP.

(Exact name of registrant as specified in its charter)

 
Delaware
(State or Other Jurisdiction of Incorporation)
001-41186
(Commission File Number)
  87-1583942
(IRS Employer
Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey
(Address of principal executive offices)
  07054
(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000
N/A
(Former name or former address, if changed since last report)
     

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class

Trading symbol(s)

Name of each exchange
on which registered

Common Stock, par value $0.01 per share EMBC The Nasdaq Stock Market LLC (Nasdaq Global Select Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

  

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

Embecta Corp. (“embecta”) held its Annual Meeting of Stockholders on February 11, 2026 (the “2026 Annual Meeting”). The final voting results for each of the matters submitted to a vote of stockholders at the 2026 Annual Meeting are as follows:

 

Proposal No. 1: All of the Board of Directors’ nominees for director were elected to serve for a term of one year (until the 2027 annual meeting of stockholders), by the votes set forth in the table below.

 

Nominee For Against Abstain Broker Non-Vote
Carrie L. Anderson 47,769,322 693,720 63,471 4,679,180
Robert (Bob) J. Hombach 48,372,760 99,877 53,876 4,679,180
Devdatt (Dev) Kurdikar 47,928,246 542,967 55,300 4,679,180
Milton M. Morris, Ph.D. 48,370,925 103,462 52,126 4,679,180
Claire Pomeroy, M.D. 47,544,291 933,330 48,892 4,679,180
Karen N. Prange 48,197,900 266,381 62,232 4,679,180
Christopher R. Reidy 45,774,127 2,703,053 49,333 4,679,180

 

 

Proposal No. 2: The appointment of Ernst & Young LLP as embecta’s independent registered public accounting firm for fiscal year 2026 was ratified by the stockholders by the votes set forth in the table below.

For Against Abstain Broker Non-Votes
53,083,728 55,489 66,476 N/A

 

Proposal No. 3: The stockholders approved, on an advisory, non-binding basis, the compensation of embecta’s named executive officers by the votes set forth in the table below.

For Against Abstain Broker Non-Votes
47,665,209 786,816 74,488 4,679,180

 

Proposal No. 4: The stockholders approved an amendment to the Embecta Corp. 2022 Employee and Director Equity-Based Compensation Plan by the votes set forth in the table below.

 

For Against Abstain Broker Non-Votes
41,396,703 7,034,781 95,029 4,679,180

 

 

 

 

 

 

 

 

 

 

  

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 13, 2026 EMBECTA CORP.
   
By:/s/ Jeff Mann
  Jeff Mann
  Senior Vice President, General Counsel & Product Development, and Corporate Secretary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FAQ

What did Embecta Corp. (EMBC) announce in its latest 8-K filing?

Embecta Corp. reported the results of its 2026 Annual Meeting of Stockholders. Shareholders elected all director nominees, ratified Ernst & Young LLP as auditor for 2026, approved executive compensation on an advisory basis, and approved an amendment to the 2022 equity-based compensation plan.

Were all Embecta Corp. (EMBC) director nominees elected at the 2026 annual meeting?

Yes, all seven Embecta Corp. board nominees were elected to one-year terms. Each nominee received more than 45 million votes "For," with some exceeding 48 million, and all had relatively low "Against" and abstention totals, alongside 4,679,180 broker non-votes reported for each nominee.

Did Embecta Corp. (EMBC) stockholders ratify the independent auditor for 2026?

Yes. Stockholders ratified Ernst & Young LLP as Embecta Corp.’s independent registered public accounting firm for fiscal 2026. The vote totaled 53,083,728 "For," 55,489 "Against," and 66,476 abstentions, with no broker non-votes reported for this ratification proposal at the meeting.

How did Embecta Corp. (EMBC) shareholders vote on executive compensation?

Shareholders approved, on an advisory and non-binding basis, the compensation of Embecta’s named executive officers. The proposal received 47,665,209 votes "For," 786,816 "Against," and 74,488 abstentions, with 4,679,180 broker non-votes. This reflects majority support for the company’s current executive pay program.

What change was approved to Embecta Corp.’s 2022 equity-based compensation plan?

Stockholders approved an amendment to the Embecta Corp. 2022 Employee and Director Equity-Based Compensation Plan. The proposal received 41,396,703 votes "For," 7,034,781 "Against," and 95,029 abstentions, along with 4,679,180 broker non-votes, indicating solid but more mixed support than other meeting items.

When was Embecta Corp.’s 2026 Annual Meeting of Stockholders held?

Embecta Corp. held its 2026 Annual Meeting of Stockholders on February 11, 2026. At this meeting, investors voted on director elections, auditor ratification, an advisory vote on executive compensation, and an amendment to the 2022 Employee and Director Equity-Based Compensation Plan, all of which received shareholder approval.

Filing Exhibits & Attachments

3 documents
Embecta Corp

NASDAQ:EMBC

EMBC Rankings

EMBC Latest News

EMBC Latest SEC Filings

EMBC Stock Data

569.10M
57.90M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
WILMINGTON